Molecular Templates, Inc.

Pharmaceutical Preparations·AUSTIN, TX

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q2 2024	6/30/24	8/14/24	→
10-Q	Q1 2024	3/31/24	5/15/24	→
10-K/A	FY 2023	12/31/23	4/25/24	→
10-K	FY 2023	12/31/23	3/29/24	→
10-Q	Q3 2023	9/30/23	11/13/23	→
10-Q	Q2 2023	6/30/23	8/10/23	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
8/14/24	Q3 FY2024	→
5/15/24	Q2 FY2024	→
3/29/24	Q1 FY2024	→
11/13/23	Q4 FY2023	→
8/10/23	Q3 FY2023	→
5/15/23	Q2 FY2023	→
↓

News (8-K)

56 shown

Filed	Type	Description
4/24/25	Agreement	Entry into a Material Definitive Agreement	→
2/26/25	Agreement	Entry into a Material Definitive Agreement	→
1/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/19/24	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
12/4/24	Vote	Submission of Matters to a Vote of Security Holders	→
12/4/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/13/24	ARS	ARS	→
5/3/24	424B3	424B3	→
4/25/24	S-3	S-3	→
3/29/24	S-8	S-8	→
9/12/23	ARS	ARS	→
8/10/23	S-3	S-3	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

25-NSE

May 22, 2025

0001354457-25-000447

—

3.7 KB

8-K

Apr 24, 2025

0001641172-25-006026

Apr 20, 2025

462.2 KB

8-K

Feb 26, 2025

0001493152-25-008399

Feb 20, 2025

855.1 KB

SCHEDULE 13G/A

Feb 12, 2025

0001104659-25-012140

—

8.1 KB

8-K

Jan 2, 2025

0001193125-25-0006478-K

Dec 30, 2024

145.9 KB

8-K

Dec 19, 2024

0001193125-24-2820168-K

Dec 16, 2024

144.7 KB

DEFA14A

Dec 4, 2024

0001193125-24-270690DEFA14A

—

15.9 KB

8-K

Dec 4, 2024

0001193125-24-2706808-K

Dec 4, 2024

139.5 KB

8-K

Dec 4, 2024

0001193125-24-2702808-K

Nov 27, 2024

143.8 KB

DEFA14A

Nov 26, 2024

0001193125-24-266148DEFA14A

—

19.1 KB

8-K

Nov 26, 2024

0001193125-24-2661418-K

Nov 25, 2024

158.2 KB

SC 13G/A

Nov 18, 2024

0001193125-24-261147SC 13G/A

—

46.4 KB

Nov 18, 2024

0000950170-24-1282084

Nov 14, 2024

10.9 KB

NT 10-Q

Nov 15, 2024

0001193125-24-259298NT 10-Q

Sep 30, 2024

25.6 KB

SC 13G/A

Nov 14, 2024

0000921895-24-002734AMENDMENT NO. 7 TO SCHEDULE 13G

—

275.9 KB

SC 13G/A

Nov 12, 2024

0000902664-24-006399MOLECULAR TEMPLATES, INC.

—

68.7 KB

DEF 14A

Oct 28, 2024

0001193125-24-245652DEF 14A

Nov 26, 2024

1.6 MB

PRE 14A

Oct 17, 2024

0001193125-24-238955PRE 14A

Oct 17, 2024

1.3 MB

8-K

Oct 11, 2024

0001193125-24-2367708-K

Oct 11, 2024

148.2 KB

8-K

Oct 4, 2024

0001193125-24-2330398-K

Oct 3, 2024

143.6 KB

Sep 30, 2024

0000950170-24-1104654

Sep 27, 2024

5.2 KB

Sep 30, 2024

0000950170-24-1104614

Sep 27, 2024

5.2 KB

Sep 30, 2024

0000950170-24-1104574

Sep 27, 2024

5.1 KB

Sep 30, 2024

0000950170-24-1104564

Sep 27, 2024

5.2 KB

Sep 30, 2024

0000950170-24-1104544

Sep 27, 2024

5.3 KB

25 filings shown

Molecular Templates, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/18/24	SC 13G/A	SC 13G/A	→
11/18/24	4	4	→
11/14/24	SC 13G/A	AMENDMENT NO. 7 TO SCHEDULE 13G	→
11/12/24	SC 13G/A	MOLECULAR TEMPLATES, INC.	→
9/30/24	4	4	→
9/30/24	4	4	→
↓

Filed	Form	Description
5/22/25	25-NSE	25-NSE	→
2/12/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/3/24	EFFECT	EFFECT	→
8/18/23	EFFECT	EFFECT	→
7/31/23	D	D	→
8/17/20	EFFECT	EFFECT	→
↓